BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1348011)

  • 1. Prefrontal lobotomy and hypofrontality in patients with schizophrenia: an integration of the findings.
    Goumeniouk AD; Clark CM
    Can J Psychiatry; 1992 Feb; 37(1):17-22. PubMed ID: 1348011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patient with schizophrenia presenting with post-lobotomy catatonia treated with olanzapine: a case report.
    Kumagai R; Kitazawa M; Ishibiki Y; Narumi K; Ichimiya Y
    Psychogeriatrics; 2017 May; 17(3):202-203. PubMed ID: 27405248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An autopsy case of the schizophrenic 32 years after lobotomy.
    Arai Y; Tsutsui Y; Shinmura Y; Kosugi T; Nishikage H; Yamamoto J
    Neuropathology; 2001 Mar; 21(1):53-60. PubMed ID: 11304043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversibility of hemodynamic hypofrontality in schizophrenia.
    Geraud G; Arné-Bès MC; Güell A; Bes A
    J Cereb Blood Flow Metab; 1987 Feb; 7(1):9-12. PubMed ID: 2879850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal dysfunction of the frontal lobe in schizophrenia.
    Pae CU; Choe BY; Joo RH; Lim HK; Kim TS; Yoo SS; Choi BG; Kim JJ; Lee SJ; Lee C; Paik IH; Lee CU
    Neuropsychobiology; 2004; 50(3):211-5. PubMed ID: 15365217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia.
    Weinberger DR; Berman KF
    Schizophr Bull; 1988; 14(2):157-68. PubMed ID: 3059465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofrontality in schizophrenic patients and its relevance for the choice of antipsychotic medication: an event-related potential study.
    Ehlis AC; Pauli P; Herrmann MJ; Plichta MM; Zielasek J; Pfuhlmann B; Stöber G; Ringel T; Jabs B; Fallgatter AJ
    World J Biol Psychiatry; 2012 Mar; 13(3):188-99. PubMed ID: 21517702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resting hypofrontality in schizophrenia: A study using near-infrared time-resolved spectroscopy.
    Hoshi Y; Shinba T; Sato C; Doi N
    Schizophr Res; 2006 Jun; 84(2-3):411-20. PubMed ID: 16626944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrograde degeneration of the thalamus following self-inflicted prefrontal lobotomy; comparative study with cases of surgical lobotomy.
    GONDA VE; MALAMUD N
    Trans Am Neurol Assoc; 1954; 13(79th Meeting):192-4. PubMed ID: 13238356
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence of fronto-thalamic involvement in schizophrenia.
    Sitskoorn MM; Appels MC; Hulshoff Pol HE; Kahn RS
    Prog Brain Res; 2000; 126():343-55. PubMed ID: 11105656
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine, the prefrontal cortex and schizophrenia.
    Knable MB; Weinberger DR
    J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies.
    Hill K; Mann L; Laws KR; Stephenson CM; Nimmo-Smith I; McKenna PJ
    Acta Psychiatr Scand; 2004 Oct; 110(4):243-56. PubMed ID: 15352925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory symptomatic schizophrenia resulting from frontal lobe lesion: response to clozapine.
    Burke JG; Dursun SM; Reveley MA
    J Psychiatry Neurosci; 1999 Nov; 24(5):456-61. PubMed ID: 10586537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early effects of treatment on regional cerebral blood flow in first episode schizophrenia patients evaluated with 99Tc-ECD-SPECT.
    Novak B; Milcinski M; Grmek M; Kocmur M
    Neuro Endocrinol Lett; 2005 Dec; 26(6):685-9. PubMed ID: 16380684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontal lobe alterations in schizophrenia: neuroimaging and neuropsychological findings.
    de la Torre JC; Barrios M; Junqué C
    Eur Arch Psychiatry Clin Neurosci; 2005 Aug; 255(4):236-44. PubMed ID: 16133741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofrontality in schizophrenia: a review of the evidence.
    Williamson P
    Can J Psychiatry; 1987 Jun; 32(5):399-404. PubMed ID: 3308053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis.
    Davidson LL; Heinrichs RW
    Psychiatry Res; 2003 Feb; 122(2):69-87. PubMed ID: 12714172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.